$42 million settlement

In this whistleblower action, we represented a sales representative who exposed her the drug manufacturer’s fraudulent scheme to unlawfully sell a drug “off-label.” After the U.S. Department of Justice intervened, a $42 million settlement was reached, with $5.7 million allocated to our client.